Skip to main content
Erschienen in: Rheumatology International 5/2018

01.03.2018 | Observational Research

Low- and high-anxious hypermobile Ehlers–Danlos syndrome patients: comparison of psychosocial and health variables

verfasst von: Carolina Baeza-Velasco, Caroline Bourdon, Lucile Montalescot, Cécile de Cazotte, Guillem Pailhez, Antonio Bulbena, Claude Hamonet

Erschienen in: Rheumatology International | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Despite the frequent co-ocurrence of hypermobile Ehler–Danlos syndrome (hEDS) and pathological anxiety, little is known about the psychosocial and health implications of such comorbidity. Our aim was to explore the association between high levels of anxiety and psychosocial (catastrophizing, kinesiophobia, somatosensory amplification, social support and functioning), health (pain, fatigue, BMI, tobacco/alcohol use, depression, diagnosis delay, general health), and sociodemographic factors in people with hEDS. In this cross-sectional study, 80 hEDS patients were divided into two groups according to self-reported anxiety levels: low and high. Psychosocial, sociodemographic and health variables were compared between the groups. Forty-one participants reported a high level of anxiety (51.2%). No differences were found in the sociodemographic variables between high-anxious and low-anxious patients. The percentage of participants with severe fatigue and high depressive symptomatology was significantly higher in the high-anxious group (80.5 vs 56.4; 26.8 vs 12.8%, respectively). High-anxious hEDS patients also showed significantly higher levels of pain catastrophizing, somatosensory amplification as well as a poorer social functioning and general health. Multivariate analyses showed that somatosensory amplification, pain catastrophizing and poor social functioning are variables that increase the probability of belonging to the high-anxious group. Despite limitations, this first study comparing high-anxious versus low-anxious hEDS patients with respect to health aspects, highlight the importance of considering the psychosocial factors (many susceptible to modification), to improve the adjustment to this chronic condition and provide support to those affected through a biopsychosocial approach.
Literatur
1.
Zurück zum Zitat Malfait F, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, de Backer J, de Paepe A, Fournel-Gigleux, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavalle ME, Levy H, Mendoza-Londono R, Pepin M, Pope M, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GL, Van Damme T, Vandersteen A, Van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B (2017) The 2017 international classification on the Ehlers–Danlos syndromes. Am J Med Genet 175C:148–157 Malfait F, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, de Backer J, de Paepe A, Fournel-Gigleux, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavalle ME, Levy H, Mendoza-Londono R, Pepin M, Pope M, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GL, Van Damme T, Vandersteen A, Van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B (2017) The 2017 international classification on the Ehlers–Danlos syndromes. Am J Med Genet 175C:148–157
2.
Zurück zum Zitat Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1998) Ehlers–Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers–Danlos National Foundation (USA) and Ehlers–Danlos Support Group (UK). Am J Med Genet 77:31–37CrossRefPubMed Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1998) Ehlers–Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers–Danlos National Foundation (USA) and Ehlers–Danlos Support Group (UK). Am J Med Genet 77:31–37CrossRefPubMed
3.
Zurück zum Zitat Steinmann B, Royce PM, Superti-Furga A (2002) The Ehlers–Danlos syndrome. In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders. Wiley-Liss, New York, pp 431–524CrossRef Steinmann B, Royce PM, Superti-Furga A (2002) The Ehlers–Danlos syndrome. In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders. Wiley-Liss, New York, pp 431–524CrossRef
4.
Zurück zum Zitat Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, Levy H (2017) Hypermobile Ehlers–Danlos Syndrome (a.k.a. Ehlers–Danlos syndrome type III and Ehlers–Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet 175C:48–69CrossRef Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, Levy H (2017) Hypermobile Ehlers–Danlos Syndrome (a.k.a. Ehlers–Danlos syndrome type III and Ehlers–Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet 175C:48–69CrossRef
5.
Zurück zum Zitat Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 27:1777–1779PubMed Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 27:1777–1779PubMed
6.
Zurück zum Zitat Tinkle BT, Bird HA Grahame R, Lavallee M, Levy HP, Sillence D (2009) The lack of clinical distinction between the hypermobility type of Ehlers–Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet 149A:2368–2370CrossRefPubMed Tinkle BT, Bird HA Grahame R, Lavallee M, Levy HP, Sillence D (2009) The lack of clinical distinction between the hypermobility type of Ehlers–Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet 149A:2368–2370CrossRefPubMed
7.
Zurück zum Zitat Colombi M, Dordoni C, Chiarelli N, Ritelli M (2015) Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type compared to other heritable connective tissue disorders. Am J Med Genet 169C:6–22CrossRefPubMed Colombi M, Dordoni C, Chiarelli N, Ritelli M (2015) Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type compared to other heritable connective tissue disorders. Am J Med Genet 169C:6–22CrossRefPubMed
8.
Zurück zum Zitat Hamonet C, Gompel A, Raffray Y, Zeitoun JD, Delarue M, Vlamynck E, Haidar R, Mazaltarine G (2014) Multiple pains in Ehlers–Danlos syndrome. Description and proposal of a therapy protocol. Douleurs 15:264–277. https://doi.org/10.1016/j.douler Hamonet C, Gompel A, Raffray Y, Zeitoun JD, Delarue M, Vlamynck E, Haidar R, Mazaltarine G (2014) Multiple pains in Ehlers–Danlos syndrome. Description and proposal of a therapy protocol. Douleurs 15:264–277. https://​doi.​org/​10.​1016/​j.​douler
9.
Zurück zum Zitat Grahame R (2008) Hypermobility: an important but often neglected area within rheumatology. Nat Clin Pract Rheumatol 4:522–524CrossRefPubMed Grahame R (2008) Hypermobility: an important but often neglected area within rheumatology. Nat Clin Pract Rheumatol 4:522–524CrossRefPubMed
10.
Zurück zum Zitat Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer MC, Borges GL, Bromet EJ, Demytteneare K, de Girolamo G, de Graaf R, Gureje O, Lepine JP, Haro JM, Levinson D, Oakley Browne MA, Posada-Villa J, Seedat S, Watanabe M (2009) Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain 9:883–891. https://doi.org/10.1016/j.jpain.2008.05.005 CrossRef Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer MC, Borges GL, Bromet EJ, Demytteneare K, de Girolamo G, de Graaf R, Gureje O, Lepine JP, Haro JM, Levinson D, Oakley Browne MA, Posada-Villa J, Seedat S, Watanabe M (2009) Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain 9:883–891. https://​doi.​org/​10.​1016/​j.​jpain.​2008.​05.​005 CrossRef
11.
Zurück zum Zitat Bulbena A, Baeza-Velasco C, Bulbena-Cabré A, Pailhez G, Critchley H, Chopra P, Mallorqui-Bagué N, Frank Ch, Porges S (2017) Psychiatric and psychological aspects in the Ehlers–Danlos syndrome. Am J Med Genet 175C:237–245CrossRef Bulbena A, Baeza-Velasco C, Bulbena-Cabré A, Pailhez G, Critchley H, Chopra P, Mallorqui-Bagué N, Frank Ch, Porges S (2017) Psychiatric and psychological aspects in the Ehlers–Danlos syndrome. Am J Med Genet 175C:237–245CrossRef
13.
15.
Zurück zum Zitat Baeza-Velasco C, Gély-Nargeot MC, Bulbena A, Bravo JF (2011) Joint hypermobility syndrome: problems that require psychological intervention. Rheumatol Int 31:1131–1136CrossRefPubMed Baeza-Velasco C, Gély-Nargeot MC, Bulbena A, Bravo JF (2011) Joint hypermobility syndrome: problems that require psychological intervention. Rheumatol Int 31:1131–1136CrossRefPubMed
16.
Zurück zum Zitat Berglund B, Anne-Cathrine M, Randers I (2010) Dignity not fully upheld when seeking health care: experiences expressed by individuals suffering from Ehlers–Danlos syndrome. Disabil Rehabil 32:1–7CrossRefPubMed Berglund B, Anne-Cathrine M, Randers I (2010) Dignity not fully upheld when seeking health care: experiences expressed by individuals suffering from Ehlers–Danlos syndrome. Disabil Rehabil 32:1–7CrossRefPubMed
17.
Zurück zum Zitat Berglund B, Nordström G, Lützén K (2000) Living a restricted life with Ehlers–Danlos syndrome (EDS). Int J Nurs Stud 37:111–118CrossRefPubMed Berglund B, Nordström G, Lützén K (2000) Living a restricted life with Ehlers–Danlos syndrome (EDS). Int J Nurs Stud 37:111–118CrossRefPubMed
18.
Zurück zum Zitat Baeza-Velasco C, Pailhez G, Bulbena A, Baghdadli A (2015) Joint hypermobility and the heritable disorders of connective tissue: clinical and empirical evidence of links with psychiatry. Gen Hosp Psychiatry 37:24–30CrossRefPubMed Baeza-Velasco C, Pailhez G, Bulbena A, Baghdadli A (2015) Joint hypermobility and the heritable disorders of connective tissue: clinical and empirical evidence of links with psychiatry. Gen Hosp Psychiatry 37:24–30CrossRefPubMed
19.
Zurück zum Zitat Gratacos M, Nadal M, Martin-Santos R, Pujana MA, Gago J, Peral B, Armengol L, Ponsa I, Miro R, Bulbena A, Estivill X (2001) A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 106:367–379CrossRefPubMed Gratacos M, Nadal M, Martin-Santos R, Pujana MA, Gago J, Peral B, Armengol L, Ponsa I, Miro R, Bulbena A, Estivill X (2001) A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 106:367–379CrossRefPubMed
20.
Zurück zum Zitat Baeza-Velasco C, Gély-Nargeot MC, Bulbena A, Fénétrier C, Bravo JF (2011) Association between psychopathological factors and joint hypermobility syndrome in a group of undergraduates from a French university. Int J Psychiatry Med 41:187–201CrossRefPubMed Baeza-Velasco C, Gély-Nargeot MC, Bulbena A, Fénétrier C, Bravo JF (2011) Association between psychopathological factors and joint hypermobility syndrome in a group of undergraduates from a French university. Int J Psychiatry Med 41:187–201CrossRefPubMed
23.
Zurück zum Zitat Mallorqui-Bagué N, Garfinkel SN, Engels M, Eccles JA, Pailhez G, Bulbena A, Critchley HD (2014) Neuroimaging and psychophysiological investigation of the link between anxiety, enhanced affective reactivity and interoception in people with joint hypermobility. Front Psychol 5:1162PubMedPubMedCentral Mallorqui-Bagué N, Garfinkel SN, Engels M, Eccles JA, Pailhez G, Bulbena A, Critchley HD (2014) Neuroimaging and psychophysiological investigation of the link between anxiety, enhanced affective reactivity and interoception in people with joint hypermobility. Front Psychol 5:1162PubMedPubMedCentral
24.
Zurück zum Zitat Bart O, Bar-Haim Y, Weizman E, Levin M, Sadeh A, Mintz M (2009) Balance treatment ameliorates anxiety and increases self-esteem in children with comorbid anxiety and balance disorder. Res Dev Disabil 30:486–495CrossRefPubMed Bart O, Bar-Haim Y, Weizman E, Levin M, Sadeh A, Mintz M (2009) Balance treatment ameliorates anxiety and increases self-esteem in children with comorbid anxiety and balance disorder. Res Dev Disabil 30:486–495CrossRefPubMed
25.
Zurück zum Zitat Balaban CD, Thayer JF (2001) Neurological bases for balance-anxiety links. J Anxiety Dis 15:53–79CrossRef Balaban CD, Thayer JF (2001) Neurological bases for balance-anxiety links. J Anxiety Dis 15:53–79CrossRef
28.
Zurück zum Zitat Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT (1999) Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers–Danlos syndrome. J Pediatr 135:494–499CrossRefPubMed Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT (1999) Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers–Danlos syndrome. J Pediatr 135:494–499CrossRefPubMed
29.
Zurück zum Zitat De Wandele I, Rombaut L, De Backer T, Peersman W, Da Silva H, De Mits S, De Paepe A, Calders P, Malfait F (2016) Orthostatic intolerance and fatigue in the hypermobile type of Ehlers–Danlos syndrome. Rheumatology 55(8):1412–1420CrossRefPubMed De Wandele I, Rombaut L, De Backer T, Peersman W, Da Silva H, De Mits S, De Paepe A, Calders P, Malfait F (2016) Orthostatic intolerance and fatigue in the hypermobile type of Ehlers–Danlos syndrome. Rheumatology 55(8):1412–1420CrossRefPubMed
30.
Zurück zum Zitat Hakim A, De Wandele I, O’Callaghan C, Pocinki A, Rowe P (2017) Chronic fatigue in Ehlers–Danlos syndrome-hypermobility type. Am J Med Genet 175C:175–180CrossRef Hakim A, De Wandele I, O’Callaghan C, Pocinki A, Rowe P (2017) Chronic fatigue in Ehlers–Danlos syndrome-hypermobility type. Am J Med Genet 175C:175–180CrossRef
32.
Zurück zum Zitat Zeitoun J-D, Lefèvre JH, de Parades V, Séjourné C, Sobhani I, Coffin B, Hamonet C (2013) Functional digestive symptoms and quality of life in patients with Ehlers– Danlos syndromes: results of a national cohort study on 134 patients. PLoS One 8:e80321CrossRefPubMedPubMedCentral Zeitoun J-D, Lefèvre JH, de Parades V, Séjourné C, Sobhani I, Coffin B, Hamonet C (2013) Functional digestive symptoms and quality of life in patients with Ehlers– Danlos syndromes: results of a national cohort study on 134 patients. PLoS One 8:e80321CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Zigmond A. Snaith R (1983) The hospital anxiety and depression scale. Acta Psiquiatr Scand 67:361–370CrossRef Zigmond A. Snaith R (1983) The hospital anxiety and depression scale. Acta Psiquiatr Scand 67:361–370CrossRef
34.
Zurück zum Zitat Lépine JP, Godchau M, Brun P, Lemperière T (1985) Evaluation de l’anxiété et de la dépression chez des patients hospitalisés dans un service de médecine interne. Annales Médico Psychologiques 43:175–189 Lépine JP, Godchau M, Brun P, Lemperière T (1985) Evaluation de l’anxiété et de la dépression chez des patients hospitalisés dans un service de médecine interne. Annales Médico Psychologiques 43:175–189
35.
Zurück zum Zitat Sarason IG, Levine HM, Basham RB, Sarason BR (1983) Assessing social support: the social support questionnaire. J Pers Soc Psychol 44:127–139CrossRef Sarason IG, Levine HM, Basham RB, Sarason BR (1983) Assessing social support: the social support questionnaire. J Pers Soc Psychol 44:127–139CrossRef
36.
Zurück zum Zitat Rascle N, Bruchon-Schweitzer M, Sarason IG (2005) Short form of Saranson’s Social Support Questionnaire: French adaptation and validation. Psychol Reports 97:195–202CrossRef Rascle N, Bruchon-Schweitzer M, Sarason IG (2005) Short form of Saranson’s Social Support Questionnaire: French adaptation and validation. Psychol Reports 97:195–202CrossRef
37.
Zurück zum Zitat Miller R, Kori S, Todd D (1991) The Tampa Scale for Kinesiophobia, Tampa, FL. (Unpublished report) Miller R, Kori S, Todd D (1991) The Tampa Scale for Kinesiophobia, Tampa, FL. (Unpublished report)
38.
Zurück zum Zitat French DJ, Roach PJ, Mayes S (2002) Peur du movement chez les accidentés du travail: l’Echelle de Kinesiophobie de Tampa (EKT). Can J Behav Sci 34:28–33CrossRef French DJ, Roach PJ, Mayes S (2002) Peur du movement chez les accidentés du travail: l’Echelle de Kinesiophobie de Tampa (EKT). Can J Behav Sci 34:28–33CrossRef
39.
Zurück zum Zitat Barsky AJ, Wyshak G, Klerman GL (1990) The somatosensory amplification scale and its relationship to hypochondriasis. J Psychiatr Res 24:323–324CrossRefPubMed Barsky AJ, Wyshak G, Klerman GL (1990) The somatosensory amplification scale and its relationship to hypochondriasis. J Psychiatr Res 24:323–324CrossRefPubMed
41.
Zurück zum Zitat Köteles F, Doering BK (2015) The many faces of somatosensory amplification: the relative contribution of body awareness, symptom labeling, and anxiety. J health Psychol 21:2903–2911CrossRefPubMed Köteles F, Doering BK (2015) The many faces of somatosensory amplification: the relative contribution of body awareness, symptom labeling, and anxiety. J health Psychol 21:2903–2911CrossRefPubMed
42.
Zurück zum Zitat French DJ, Noël M, Vigneau F (2005) L’echelle de dramatization face à la douleur PCS-CF: adaptation canadienne en langue française de l’echelle “Pain Catastrohpizing Scale”. Can J Behav Sci 37:181–192CrossRef French DJ, Noël M, Vigneau F (2005) L’echelle de dramatization face à la douleur PCS-CF: adaptation canadienne en langue française de l’echelle “Pain Catastrohpizing Scale”. Can J Behav Sci 37:181–192CrossRef
43.
Zurück zum Zitat McHorney CA, Ware JE, Raczek AE (1993) The MOS 36-item Short Form Health Survey (SF-36): II. Psychometric and clinical test of validity in measuring physical and mental health constructs. Med Care 31:247–263CrossRefPubMed McHorney CA, Ware JE, Raczek AE (1993) The MOS 36-item Short Form Health Survey (SF-36): II. Psychometric and clinical test of validity in measuring physical and mental health constructs. Med Care 31:247–263CrossRefPubMed
44.
Zurück zum Zitat Leplège A, Ecosse E, Verdier A, Perneger TV (1998) The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 51:1013–1023CrossRefPubMed Leplège A, Ecosse E, Verdier A, Perneger TV (1998) The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 51:1013–1023CrossRefPubMed
45.
Zurück zum Zitat Bulbena A, Pailhez G, Bulbena-Cabré A, Mallorqui-Bagué N, Baeza-Velasco C (2015) Joint hypermobility, anxiety and psychosomatics: two and a half decades of progress toward a bew phenotype. Adv Psychosom Med 34:143–157CrossRefPubMed Bulbena A, Pailhez G, Bulbena-Cabré A, Mallorqui-Bagué N, Baeza-Velasco C (2015) Joint hypermobility, anxiety and psychosomatics: two and a half decades of progress toward a bew phenotype. Adv Psychosom Med 34:143–157CrossRefPubMed
46.
Zurück zum Zitat Murray B, Yashar BM, Uhlmann WR, Clauw DJ, Petty EM (2013) Ehlers–Danlos syndrome, hypermobility type: a characterization of the patients’ lived experience. Am J Med Genet 161A:2981–2988CrossRefPubMed Murray B, Yashar BM, Uhlmann WR, Clauw DJ, Petty EM (2013) Ehlers–Danlos syndrome, hypermobility type: a characterization of the patients’ lived experience. Am J Med Genet 161A:2981–2988CrossRefPubMed
47.
Zurück zum Zitat Berglund B, Petterson C, Pigg M, Kristiansson (2015) Self-reported quality of life, anxiety and depression in individuals with Ehlers–Danlos syndrome (EDS): a questionnaire study. BMC Musculoskeletal Disord 16:89CrossRef Berglund B, Petterson C, Pigg M, Kristiansson (2015) Self-reported quality of life, anxiety and depression in individuals with Ehlers–Danlos syndrome (EDS): a questionnaire study. BMC Musculoskeletal Disord 16:89CrossRef
49.
Zurück zum Zitat Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K (2008) Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 70:890–897CrossRefPubMedPubMedCentral Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K (2008) Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 70:890–897CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Gazit Y, Nahir AM, Grahame R, Jacob G (2003) Dysautonomia in the joint hypermobility syndrome. Am J Med 115:33–40CrossRefPubMed Gazit Y, Nahir AM, Grahame R, Jacob G (2003) Dysautonomia in the joint hypermobility syndrome. Am J Med 115:33–40CrossRefPubMed
51.
Zurück zum Zitat Krahe AM, Adams RD, Nicholson LL (2017) Features that exacerbates fatigue severity in joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type. Disabil Rehabil 9:1–8CrossRef Krahe AM, Adams RD, Nicholson LL (2017) Features that exacerbates fatigue severity in joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type. Disabil Rehabil 9:1–8CrossRef
52.
Zurück zum Zitat Roger RR, Bonnet MH, Kramer M (1983) The relationship of sleep and anxiety in anxious subjects. Biol Psychol 16:119–126CrossRef Roger RR, Bonnet MH, Kramer M (1983) The relationship of sleep and anxiety in anxious subjects. Biol Psychol 16:119–126CrossRef
53.
Zurück zum Zitat Kendall PC, Ingram RE (1987) The future for cognitive assessment of anxiety: Let’s get specific. In: Michelson L, Ascher LM (eds) Anxiety and stress disorders: Cognitive-behavioral assessment and treatment. Guilford Press, New York Kendall PC, Ingram RE (1987) The future for cognitive assessment of anxiety: Let’s get specific. In: Michelson L, Ascher LM (eds) Anxiety and stress disorders: Cognitive-behavioral assessment and treatment. Guilford Press, New York
55.
56.
Zurück zum Zitat De Baets S, Vanhalst M, Coussens M, Rombaut L, Malfait F, Van Hove G, Calders P, Vanderstraeten G, van de Velde D (2017) The influence of Ehlers–Danlos syndrome-hypermobility type, on motherhood: a phenomenological, hermeneutical study. Res Dev Disabil 60:135–144CrossRefPubMed De Baets S, Vanhalst M, Coussens M, Rombaut L, Malfait F, Van Hove G, Calders P, Vanderstraeten G, van de Velde D (2017) The influence of Ehlers–Danlos syndrome-hypermobility type, on motherhood: a phenomenological, hermeneutical study. Res Dev Disabil 60:135–144CrossRefPubMed
57.
Zurück zum Zitat Pino-Ramirez G (2016) Empowerment, life experience and Ehlers–Danlos syndrome patient associations. Cuad Neuropsicol 10:78–94 Pino-Ramirez G (2016) Empowerment, life experience and Ehlers–Danlos syndrome patient associations. Cuad Neuropsicol 10:78–94
58.
Zurück zum Zitat Rubin KH, Burgess KB (2001) Social withdrawal and anxiety. In: Vasey MW, Dadds MR (eds) The developmental psychopathogy of anxiety. Oxford University Press, New York Rubin KH, Burgess KB (2001) Social withdrawal and anxiety. In: Vasey MW, Dadds MR (eds) The developmental psychopathogy of anxiety. Oxford University Press, New York
59.
Zurück zum Zitat Edwards RR, Bingham CO III, Bathon J, Haythirnthwaite JA (2006) Catastrophizing and pain in Arthritis, Fibromyalgia, and other rheumatic diseases. Arthritis Rheum 55:325–332CrossRefPubMed Edwards RR, Bingham CO III, Bathon J, Haythirnthwaite JA (2006) Catastrophizing and pain in Arthritis, Fibromyalgia, and other rheumatic diseases. Arthritis Rheum 55:325–332CrossRefPubMed
60.
Zurück zum Zitat Baumeister H, Balke K, Härter M (2005) Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol 58:1090–1100CrossRefPubMed Baumeister H, Balke K, Härter M (2005) Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol 58:1090–1100CrossRefPubMed
Metadaten
Titel
Low- and high-anxious hypermobile Ehlers–Danlos syndrome patients: comparison of psychosocial and health variables
verfasst von
Carolina Baeza-Velasco
Caroline Bourdon
Lucile Montalescot
Cécile de Cazotte
Guillem Pailhez
Antonio Bulbena
Claude Hamonet
Publikationsdatum
01.03.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 5/2018
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-4003-7

Weitere Artikel der Ausgabe 5/2018

Rheumatology International 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.